Editor Profile

Barbara Geller, MD

Associate Editor

About the NEJM Journal Watch Psychiatry Board

Barbara Geller, MD, is Professor Emerita of Psychiatry at Washington University in St. Louis. She is internationally recognized for research into pediatric bipolar disorders and was principal investigator on multiple NIMH-funded grants. Among her awards were the Cummings Special Research Award from the American Academy of Child and Adolescent Psychiatry and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill. Dr. Geller served on numerous federal advisory committees and published more than 130 articles on childhood manic-depressive disorders. She has been writing for NEJM Journal Watch Psychiatry since 1997, specializing in articles on child psychiatry and neuroscience.

Dr. Geller has no disclosures.

Summaries by Barbara Geller

  • November 13, 2015

    Does Oxytocin Improve Autism?

    1. Barbara Geller, MD

    Caregivers reported that nasal oxytocin significantly improved social responsiveness in a small randomized study of autistic children ages 3 to 8 years.

  • November 9, 2015

    What Predicts Two-Year Outcome of Childhood Psychosis?

    1. Barbara Geller, MD

    Negative psychopathology predicted poor outcomes, whereas greater baseline severity and later onset predicted better ones.

  • November 5, 2015

    Is Birth Order Your Destiny?

    1. Barbara Geller, MD

    Little effect of birth order on five major personality factors was seen, but risk-taking, self-confidence, and optimism were not studied.

  • October 20, 2015

    Can Adolescent Depression Be Prevented?Free

    1. Barbara Geller, MD

    A preventive cognitive-behavioral therapy was effective in decreasing future depressive episodes in high-risk teenagers but only if neither parent was depressed at baseline.

  • October 13, 2015

    Can Breast-Feeding Prevent Autism?

    1. Barbara Geller, MD

    Breast-feeding increased gaze at happy facial expressions, and decreased gaze at angry ones, in infants with an autism risk genotype.

  • October 2, 2015

    Do SSRIs Increase Violent Criminal Acts?

    1. Barbara Geller, MD

    Low doses are associated with violent crimes in 15- to 24-year-olds, according to a Swedish registry study.